Overall, our study demonstrates the utility of the radiomic model in predicting immune cell infiltration levels and the response to immunotherapy in NSCLC patients, with CD8+ T cell infiltration showing the strongest association with PFS. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.